| 1 |
Matthew Chila |
Johnson & Johnson |
6 |
| 2 |
Landy Toth |
Autonomix Medical |
4 |
| 2 |
David Grubb |
Arris Enterprises |
4 |
| 2 |
Ling Chen |
Bristol-Myers Squibb |
4 |
| #5 |
Susan Hakkarainen |
Lutron Electronics Co. |
3 |
| #5 |
Christopher Poli |
Arris Enterprises |
3 |
| #5 |
Thomas F. Kister |
Arris Enterprises |
3 |
| #5 |
John Grant Aunins |
Seres Therapeutics |
3 |
| #9 |
Joel H. Waldman |
Johnson & Johnson |
2 |
| #9 |
Kelly A. Bucey |
Wicket |
2 |
| #9 |
Gregory J. Tawa |
Loyola University Of Chicago |
2 |
| #9 |
Robert W. Carlson |
National Comprehensive Cancer Network |
2 |
| #9 |
Robert S. Hansen |
Unknown |
2 |
| #9 |
Walter Mlodzinski |
Comcast |
2 |
| #9 |
Edward A. Bani |
Johnson & Johnson |
2 |
| #9 |
Matthew Zelesko |
Time Warner Cable |
2 |
| #9 |
John Lance Perez |
Pfizer |
2 |
| #9 |
Ruey J. Yu |
Tristrata Technology |
2 |
| #9 |
Robert R. Seaner, Jr. |
Wicket |
2 |
| #9 |
Victor Steven Haidacher |
Johnson & Johnson |
2 |
| #9 |
Walter Strapps |
Sirna Therapeutics |
2 |
| #9 |
Russell Gotschall |
Amicus Therapeutics |
2 |
| #23 |
Steven Ferrante |
Interdigital Patent Holdings |
1 |
| #23 |
Siu Bor Lau |
Autonomix Medical |
1 |
| #23 |
Izzat T. Raheem |
Merck |
1 |
| #23 |
Jeremy J. HARRIS |
The Secant Group |
1 |
| #23 |
Michael Albert Winters |
Merck |
1 |
| #23 |
Matthew Wildrick |
Rovi Guides |
1 |
| #23 |
Thomas C. Savage |
Victaulic |
1 |
| #23 |
Nahor Haddish-Berhane |
Johnson & Johnson |
1 |
| #23 |
Neal Franciotti |
Lasko Operations Holdings |
1 |
| #23 |
Harry T. Rieth |
— |
1 |
| #23 |
Zhengyan Zhai |
Bio Tillion |
1 |
| #23 |
Thomas H. Richards |
Van Dorn Demag |
1 |
| #23 |
Mark C. Tsai |
Gyroscope Therapeutics Limited |
1 |
| #23 |
Steven Michael Baxter |
Rohm And Haas |
1 |
| #23 |
William R. Jones |
Columbian Chemicals |
1 |
| #23 |
David J. Pocalyko |
Johnson & Johnson |
1 |
| #23 |
Tom Barker |
Comcast |
1 |
| #23 |
Stephen Comiskey |
Synergy Pharmaceuticals |
1 |
| #23 |
Thomas R. Forbus, Jr. |
ExxonMobil |
1 |
| #23 |
Lisa Leleu |
— |
1 |
| #23 |
Jefferey Clifford Yaschur |
Ingersoll-Rand |
1 |
| #23 |
Brahm Goldstein |
Takeda Pharmaceutical Company Limited |
1 |
| #23 |
Marcelo Bigal |
— |
1 |
| #23 |
David P. Resuta |
General Instrument |
1 |
| #23 |
Mark Edward Riehl |
Neuronetics |
1 |
| #23 |
Rhys Salter |
Johnson & Johnson |
1 |
| #23 |
Michael Kansky |
Livehelpnow |
1 |
| #23 |
Shyh-Ming Yang |
Johnson & Johnson |
1 |